Tam L&M Digital therapeutics (DTx) brand Fitterfly released its year-end report called Reimagining Diabetes Care Report 2022 for the period January-December 2022. Based on a sample size of over 3,000 people who enrolled into Fitterfly’s Diabetes Management programs, the report underscores the need to reimagine, rethink, and reassess diabetes before it reaches pandemic proportions. It […]Read More
Tags : Fitterfly
Dr Arbinder Singal The times are nothing short of exciting for India’s healthcare segment. Technology has always been the panacea for several used cases related to healthcare access, but in the last year, innovations like digital therapeutics have placed patients and their health outcomes at the center of the ecosystem, enabling them to take charge […]Read More